When AI fails to thrive in healthcare, the problem is usually not with an algorithm. It’s with something deeper. Three unrelated opinion pieces authored by far-flung subject matter experts hit on this theme just this week. 

Regulators said the shortages of neurosurgery devices are likely to extend until the end of the year. Medline recalled its neurosurgical patties due to a potential toxicity issue. The FDA said it's looking for alternatives. 

The digital entity gave at least one end-user a phony medical-license number. Unfortunately for the chatbot, that end-user was a state investigator.